To explore the underlying mechanism through which NFKBIZ regulates HCC cells, we focused on three pathways known to be abnormally activated during HCC development: PI3K/AKT, Wnt/β-catenin, and NFκB. Here, NFKB1 is linked to hepatocellular carcinoma.